scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Zdenko Herceg | |
P433 | issue | 2 | |
P921 | main subject | epigenetics | Q26939 |
P304 | page(s) | 91-103 | |
P577 | publication date | 2007-02-06 | |
P1433 | published in | Mutagenesis | Q15724554 |
P1476 | title | Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors | |
P478 | volume | 22 |
Q34487211 | A cross-sectional study of global DNA methylation and risk of colorectal adenoma |
Q34113164 | A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation |
Q91484672 | A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes |
Q37949394 | An overview of cancer chemopreventive potential and safety of proanthocyanidins |
Q35999967 | Analysis of Nucleosides in Municipal Wastewater by Large-Volume Liquid Chromatography Tandem Mass Spectrometry |
Q28829867 | Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years |
Q33886934 | Association between lifestyle factors and CpG island methylation in a cancer-free population. |
Q53721508 | Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. |
Q51761835 | At the Crossroads Between Neurodegeneration and Cancer: A Review of Overlapping Biology and Its Implications. |
Q34473441 | Biochemical mutagens affect the preservation of fungi and biodiversity estimations |
Q97536301 | Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease? |
Q34279875 | Cancer chemoprevention by dietary polyphenols: promising role for epigenetics |
Q36591701 | Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk. |
Q47612846 | Colder environments are associated with a greater cancer incidence in the female population of the United States |
Q33862644 | Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes |
Q23919015 | Considerations for using genetic and epigenetic information in occupational health risk assessment and standard setting |
Q36149220 | Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer |
Q35911261 | DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract |
Q35966485 | DNA methylation dynamics in plants and mammals: overview of regulation and dysregulation. |
Q37873228 | DNA methylation in cancer development, diagnosis and therapy--multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. |
Q34195371 | DNA methylation in endometrial cancer |
Q35159029 | DNA methylation in white blood cells: association with risk factors in epidemiologic studies |
Q38038406 | Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application |
Q38018255 | Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes |
Q28384266 | Diet, the gut microbiome, and epigenetics |
Q26858886 | Dietary epigenetics in cancer and aging |
Q28472388 | Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model |
Q28395938 | Effects of arsenic exposure on DNA methylation and epigenetic gene regulation |
Q42911316 | Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders |
Q28385295 | Environmental toxicants, epigenetics, and cancer |
Q38161341 | Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer |
Q35697918 | Epigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants |
Q38876530 | Epigenetic Mechanisms as an Interface Between the Environment and Genome |
Q37345879 | Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. |
Q27022002 | Epigenetic diet: impact on the epigenome and cancer |
Q52595933 | Epigenetic information in chromatin and cancer. |
Q34457187 | Epigenetic linkage of aging, cancer and nutrition |
Q35573935 | Epigenetic mechanisms of pulmonary hypertension. |
Q37077821 | Epigenetic programming of the germ line: effects of endocrine disruptors on the development of transgenerational disease |
Q53184356 | Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. |
Q34508252 | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
Q34705578 | Epigenetic transgenerational actions of vinclozolin on the development of disease and cancer |
Q34085532 | Epigenetics and cancer |
Q34687601 | Epigenomic biomonitors: global DNA hypomethylation as a biodosimeter of life-long environmental exposures. |
Q35711392 | Epigenomics of ovarian cancer and its chemoprevention |
Q64098410 | Evaluation of DNA Methylation Changes and Micronuclei in Workers Exposed to a Construction Environment |
Q38808103 | Future of environmental research in the age of epigenomics and exposomics |
Q39760740 | Future research perspectives on environment and health: the requirement for a more expansive concept of translational cancer research |
Q38414652 | Gene-specific promoter methylation is associated with micronuclei frequency in urothelial cells from individuals exposed to organic solvents and paints |
Q40038281 | Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells |
Q35878556 | Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds |
Q36002022 | Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure. |
Q38110262 | Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis |
Q37680071 | Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma |
Q28577672 | Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis |
Q34363873 | Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells |
Q33407811 | Identification of histone modifications in biomedical text for supporting epigenomic research |
Q51187064 | Impact of Phytochemicals and Dietary Patterns on Epigenome and Cancer. |
Q33731768 | Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review |
Q28080281 | Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention |
Q57918250 | Insulin-like growth factor 2hypomethylation of blood leukocyte DNA is associated with gastric cancer risk |
Q36243658 | Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects |
Q92003943 | Key actors in cancer therapy: epigenetic modifiers |
Q64124594 | LncRNA-MALAT1 as a novel biomarker of cadmium toxicity regulates cell proliferation and apoptosis |
Q47393672 | Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma |
Q47663995 | Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer. |
Q27015643 | Maternal nutritional status, C(1) metabolism and offspring DNA methylation: a review of current evidence in human subjects |
Q38107445 | Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk |
Q93168401 | Mechanisms of DNA-reactive and epigenetic chemical carcinogens: applications to carcinogenicity testing and risk assessment |
Q37665565 | Methylation and expression of PTPN22 in esophageal squamous cell carcinoma |
Q35870726 | Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population. |
Q35053159 | Methylome analysis and epigenetic changes associated with menarcheal age |
Q33661037 | MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects |
Q34025838 | Molecular targets of epigenetic regulation and effectors of environmental influences |
Q41990459 | New Insights into the Epigenetics of Hepatocellular Carcinoma. |
Q28084085 | Nuclear and mitochondrial DNA alterations in newborns with prenatal exposure to cigarette smoke |
Q34457478 | Nutrients, foods, and colorectal cancer prevention |
Q26750817 | Nutrition, aging and cancer: lessons from dietary intervention studies |
Q37706886 | Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells |
Q42702889 | Persistent organic pollutants and promoter hypermethylation of the O(6)-methylguanine-DNA methyltransferase gene |
Q35637318 | Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective |
Q90318694 | Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma |
Q35792273 | Prospects for epigenetic epidemiology |
Q57293808 | Proteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancer |
Q37036306 | Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors |
Q33548990 | Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids |
Q35989817 | RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients |
Q38062515 | RUNX family: Regulation and diversification of roles through interacting proteins |
Q36877220 | RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. |
Q36213023 | Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α |
Q37370439 | Reactivation of RASSF1A in breast cancer cells by curcumin |
Q90122154 | Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes |
Q36401944 | Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry |
Q37206472 | Second-hand smoke and human lung cancer |
Q37301148 | Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate. |
Q64120695 | Supplementing Genistein for Breeder Hens Alters the Fatty Acid Metabolism and Growth Performance of Offsprings by Epigenetic Modification |
Q64964982 | The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation. |
Q23914496 | The association between global DNA methylation and telomere length in a longitudinal study of boilermakers |
Q36990438 | The epigenome as a potential mediator of cancer and disease prevention in prenatal development |
Q38241688 | The potential role of O-GlcNAc modification in cancer epigenetics. |
Q39846650 | The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers |
Q35159486 | The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma |
Q37151661 | Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation |
Q38776904 | Ubiquitin Protein Ligase Ring2 Is Involved in S-phase Checkpoint and DNA Damage in Cells Exposed to Benzo[a]pyrene |
Q34463056 | Unexplored potentials of epigenetic mechanisms of plants and animals-theoretical considerations |
Q28249524 | Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen |
Search more.